Endometriosis and ovarian cancer

World Journal of Clinical Oncology

Volumn 5, Issue 5, 2014, Pages 800-805

  Králíčková, Milena ^a,b   Vetvicka, Vaclav ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c University of Louisville School of Medicine   (United States)

Author keywords

Biomarkers; Cancer; Endometriosis; Histology; Ovarian cancer

Indexed keywords

EID: 84942588385     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v5.i5.800     Document Type: Review

References (65)

1. Sayasneh A, Tsivos D, Crawford R. Endometriosis and ovarian cancer: a systematic review. ISRN Obstet Gynecol 2011; 2011: 140310 [PMID: 21789283]
2. Lapp T. ACOG issues recommendations for the management of endometriosis. American College of Obstetricians and Gynecologists. Am Fam Physician 2000; 62: 1431, 1434 [PMID: 11011865]
3. von Rokytansky C. Uber uterusdrusen-neubildung in uterus inder ovarilsarcomen. Z Ges Artze Wein 1860; 37: 577-593
4. Kobayashi H, Kajihara H, Yamada Y, Tanase Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Naruse K, Sado T, Oi H. Risk of carcinoma in women with ovarian endometrioma. Front Biosci (Elite Ed) 2011; 3: 529-539 [PMID: 21196332 DOI: 10.2741/e267]
5. Arvanitis DA, Koumantakis GE, Goumenou AG, Matalliotakis IM, Koumantakis EE, Spandidos DA. CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertil Steril 2003; 79 Suppl 1: 702-709 [PMID: 12620480 DOI: 10.1016/S0015-0282(02)04817-3]
6. Baldi A, Campioni M, Signorile PG. Endometriosis: pathogenesis, diagnosis, therapy and association with cancer (review). Oncol Rep 2008; 19: 843-846 [PMID: 18357365]
7. Yuan Z, Wang Y, Cragun JM, Chambers SK, Zheng W. Cell origin of endometriosis: contribution by the fallopian tube epithelium. Am J Clin Obstet Gynecol 2013; 1: 37-42
8. Thomas EJ, Prentice A. The aetiology and pathogenesis of endometriosis. Reprod Med Rev 1992; 1: 21-36 [DOI: 10.1017/S0962279900000429]
9. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2014; 10: 261-275 [PMID: 24366116 DOI: 10.1038/nrendo.2013.255]
10. Sampson J. Endometrial carcinoma of the ovary arising in endometrial tissue of that organ. Arch Surg 1925; 10: 1-72 [DOI: 10.1001/archsurg.1925.01120100007001]
11. Scott RB. Malignant changes in endometriosis. Obstet Gynecol 1953; 2: 283-289 [PMID: 13087921]
12. LaGrenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988; 19: 1080-1084 [PMID: 3417292 DOI: 10.1016/S0046-8177(88)80090-X]
13. Maiorana A, Cicerone C, Niceta M, Alio L. Evaluation of serum CA 125 levels in patients with pelvic pain related to endometriosis. Int J Biol Markers 2007; 22: 200-202 [PMID: 17922463]
14. Vlahos NF, Kalampokas T, Fotiou S. Endometriosis and ovarian cancer: a review. Gynecol Endocrinol 2010; 26: 213-219 [PMID: 19718562 DOI: 10.1080/09513590903184050]
15. Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Ovarian and extraovarian endometriosisassociated cancer. Obstet Gynecol 2002; 100: 788-795 [PMID: 12383550 DOI: 10.1016/S0029-7844(02)02149-X]
16. Dzatic-Smiljkovic O, Vasiljevic M, Djukic M, Vugdelic R, Vugdelic J. Frequency of ovarian endometriosis in epithelial ovarian cancer patients. Clin Exp Obstet Gynecol 2011; 38: 394-398 [PMID: 22268283]
17. Wang S, Qiu L, Lang JH, Shen K, Yang JX, Huang HF, Pan LY, Wu M. Clinical analysis of ovarian epithelial carcinoma with coexisting pelvic endometriosis. Am J Obstet Gynecol 2013; 208: 413.e1-413.e5 [PMID: 23220508 DOI: 10.1016/j.ajog.2012.12.004]
18. Buis CC, van Leeuwen FE, Mooij TM, Burger CW. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod 2013; 28: 3358-3369 [PMID: 24014607 DOI: 10.1093/humrep/det340]
19. Heidemann LN, Hartwell D, Heidemann CH, Jochumsen KM. The relation between endometriosis and ovarian cancer - a review. Acta Obstet Gynecol Scand 2014; 93: 20-31 [PMID: 24011403 DOI: 10.1111/aogs.12255]
20. Hunn J, Rodriguez GC. Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 2012; 55: 3-23 [PMID: 22343225 DOI: 10.1097/GRF.0b013e31824b4611]
21. Kim HS, Kim TH, Chung HH, Song YS. Risk and prognosis of ovarian cancer in women with endometriosis: a metaanalysis. Br J Cancer 2014; 110: 1878-1890 [PMID: 24518590 DOI: 10.1038/bjc.2014.29]
22. Garrett LA, Growdon WB, Goodman A, Boruta DM, Schorge JO, del Carmen MG. Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment, and outcome. J Reprod Med 2013; 58: 469-476 [PMID: 24568040]
23. Qiu L, Wang S, Lang JH, Shen K, Huang HF, Pan LY, Wu M, Yang JX. The occurrence of endometriosis with ovarian carcinomas is not purely coincidental. Eur J Obstet Gynecol Reprod Biol 2013; 170: 225-228 [PMID: 23866908 DOI: 10.1016/j.ejogrb.2013.06.015]
24. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997; 176: 572-579 [PMID: 9077609 DOI: 10.1016/S0002-9378(97)70550-7]
25. Bertelsen L, Mellemkjaer L, Frederiksen K, Kjaer SK, Brinton LA, Sakoda LC, van Valkengoed I, Olsen JH. Risk for breast cancer among women with endometriosis. Int J Cancer 2007; 120: 1372-1375 [PMID: 17187365 DOI: 10.1002/ijc.22490]
26. Kobayashi H, Sumimoto K, Kitanaka T, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S, Terao T. Ovarian endometrioma-risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol 2008; 138: 187-193 [PMID: 18162283 DOI: 10.1016/j.ejogrb.2007.06.017]
27. Shushan A, Revel A, Rojansky N. How often are endometrial polyps malignant? Gynecol Obstet Invest 2004; 58: 212-215 [PMID: 15316149 DOI: 10.1159/000080189]
28. Kontoravdis A, Augoulea A, Lambrinoudaki I, Christodoulakos G, Tzortziotis D, Grammatikakis I, Kontoravdis N, Creatsas G. Ovarian endometriosis associated with ovarian cancer and endometrial-endocervical polyps. J Obstet Gynaecol Res 2007; 33: 294-298 [PMID: 17578358 DOI: 10.1111/j.1447-0756.2007.00527.x]
29. Kobayashi H. Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis. Int J Clin Oncol 2009; 14: 378-382 [PMID: 19856043 DOI: 10.1007/s10147-009-0931-2]
30. Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y, Nozawa S. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol 1999; 72: 342-346 [PMID: 10053105 DOI: 10.1006/gyno.1998.5284]
31. Noli S, Cipriani S, Scarfone G, Villa A, Grossi E, Monti E, Vercellini P, Parazzini F. Long term survival of ovarian endometriosis associated clear cell and endometrioid ovarian cancers. Int J Gynecol Cancer 2013; 23: 244-248 [PMID: 23314280 DOI: 10.1097/IGC.0b013e31827aa0bb]
32. Melin A, Lundholm C, Malki N, Swahn ML, Sparen P, Bergqvist A. Endometriosis as a prognostic factor for cancer survival. Int J Cancer 2011; 129: 948-955 [PMID: 20949560 DOI: 10.1002/ijc.25718]
33. Melin AS, Lundholm C, Malki N, Swahn ML, Sparèn P, Bergqvist A. Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer. Acta Obstet Gynecol Scand 2013; 92: 546-554 [PMID: 23560387 DOI: 10.1111/aogs.12123]
34. Kashyap S, Davis OK. Ovarian cancer and fertility medications: a critical appraisal. Semin Reprod Med 2003; 21: 65-71 [PMID: 12806561 DOI: 10.1055/s-2003-39996]
35. Oxholm D, Knudsen UB, Kryger-Baggesen N, Ravn P. Postmenopausal endometriosis. Acta Obstet Gynecol Scand 2007; 86: 1158-1164 [PMID: 17851817 DOI: 10.1080/0001634070161 9407]
36. Seeger H, Wallwiener D, Kraemer E, Mueck AO. Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells. Eur J Gynaecol Oncol 2005; 26: 383-385 [PMID: 16122183]
37. Lenhard M, Tereza L, Heublein S, Ditsch N, Himsl I, Mayr D, Friese K, Jeschke U. Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival. BMC Cancer 2012; 12: 553 [PMID: 23176303 DOI: 10.1186/1471-2407-12-553]
38. Rogers PA, Donoghue JF, Walter LM, Girling JE. Endometrial angiogenesis, vascular maturation, and lymphangiogenesis. Reprod Sci 2009; 16: 147-151 [PMID: 19001552 DOI: 10.1177/1933719108325509]
39. Maruyama T, Yoshimura Y. Stem cell theory for the pathogenesis of endometriosis. Front Biosci (Elite Ed) 2012; 4: 2854-2863 [PMID: 22652684 DOI: 10.2741/E589]
40. Cheng W, Liu J, Yoshida H, Rosen D, Naora H. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med 2005; 11: 531-537 [PMID: 15821746 DOI: 10.1038/nm1230]
41. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 2005; 65: 3025-3029 [PMID: 15833827]
42. Duke CM, Taylor HS. Stem cells and the reproductive system: historical perspective and future directions. Maturitas 2013; 76: 284-289 [PMID: 24144960 DOI: 10.1016/j.maturitas.2013.08.012]
43. Vlahos NF, Economopoulos KP, Fotiou S. Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer. Best Pract Res Clin Obstet Gynaecol 2010; 24: 39-50 [PMID: 19733123 DOI: 10.1016/j.bpobgyn.2009.08.004]
44. Meng Q, Sun W, Jiang J, Fletcher NM, Diamond MP, Saed GM. Identification of common mechanisms between endometriosis and ovarian cancer. J Assist Reprod Genet 2011; 28: 917-923 [PMID: 21614520 DOI: 10.1007/s10815-011-9573-1]
45. Anastasi E, Manganaro L, Granato T, Benedetti Panici P, Frati L, Porpora MG. Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer? Dis Markers 2013; 35: 331-335 [PMID: 24191126 DOI: 10.1155/2013/984641]
46. Lai CR, Hsu CY, Chen YJ, Yen MS, Chao KC, Li AF. Ovarian cancers arising from endometriosis: a microenvironmental biomarker study including ER, HNF1β, p53, PTEN, BAF250a, and COX-2. J Chin Med Assoc 2013; 76: 629-634 [PMID: 23962610 DOI: 10.1016/j.jcma.2013.07.008]
47. Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel M, Lee T, Mansuria S, Elishaev E, Budiu R, Edwards RP, Huang X. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2013; 19: 1213-1224 [PMID: 23362326 DOI: 10.1158/1078-0432.CCR-12-2726]
48. Siufi Neto J, Kho RM, Siufi DF, Baracat EC, Anderson KS, Abrão MS. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer. J Minim Invasive Gynecol 2014; 21: 55-63 [PMID: 23962574 DOI: 10.1016/j.jmig.2013.07.021]
49. Ness RB. Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 2003; 189: 280-294 [PMID: 12861175 DOI: 10.1067/mob.2003.408]
50. Viganó P, Somigliana E, Chiodo I, Abbiati A, Vercellini P. Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Hum Reprod Update 2012; 12: 77-89 [PMID: 16172112 DOI: 10.1093/humupd/dmi037]
51. Zachos G, Spandidos DA. Transcriptional regulation of the c-Hras1 gene by the P53 protein is implicated in the development of human endometrial and ovarian tumours. Oncogene 1998; 16: 3013-3017 [PMID: 9662334 DOI: 10.1038/sj.onc.1201836]
52. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 2005; 11: 63-70 [PMID: 15619626]
53. Otsuka J, Okuda T, Sekizawa A, Amemiya S, Saito H, Okai T, Kushima M, Tachikawa T. K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma. Med Electron Microsc 2004; 37: 188-192 [PMID: 15449112 DOI: 10.1007/s00795-004-0252-5]
54. Yamamoto S, Tsuda H, Takano M, Iwaya K, Tamai S, Matsubara O. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma. J Pathol 2011; 225: 189-194 [PMID: 21735444 DOI: 10.1002/path.2940]
55. Gounaris I, Charnock-Jones DS, Brenton JD. Ovarian clear cell carcinoma-bad endometriosis or bad endometrium? J Pathol 2011; 225: 157-160 [PMID: 21898874 DOI: 10.1002/path.2970]
56. Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, Fujii S. Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res 2008; 14: 32-40 [PMID: 18172249 DOI: 10.1158/1078-0432. CCR-07-1614]
57. Meresman GF, Vighi S, Buquet RA, Contreras-Ortiz O, Tesone M, Rumi LS. Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril 2000; 74: 760-766 [PMID: 11020520 DOI: 10.1016/S0015-0282(00)01522-3]
58. Martini M, Ciccarone M, Garganese G, Maggiore C, Evangelista A, Rahimi S, Zannoni G, Vittori G, Larocca LM. Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. Int J Cancer 2002; 102: 398-406 [PMID: 12402310 DOI: 10.1002/ijc.10715]
59. Prefumo F, Venturini PL, Fulcheri E. Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis. Int J Gynecol Pathol 2003; 22: 83-88 [PMID: 12496703 DOI: 10.1097/00004347-200301000-00016]
60. Romero I, Bast RC. Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology 2012; 153: 1593-1602 [PMID: 22416079 DOI: 10.1210/en.2011-2123]
61. Tempfer CB, Simoni M, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: part II-endometriosis. Hum Reprod Update 2009; 15: 97-118 [PMID: 18805939 DOI: 10.1093/humupd/dmn040]
62. Falconer H, Sundqvist J, Xu H, Vodolazkaia A, Fassbender A, Kyama C, Bokor A, D'Hooghe TM. Analysis of common variations in tumor-suppressor genes on chr1p36 among Caucasian women with endometriosis. Gynecol Oncol 2012; 127: 398-402 [PMID: 22910690 DOI: 10.1016/j.ygyno.2012.08.013]
63. Shigetomi H, Tsunemi T, Haruta S, Kajihara H, Yoshizawa Y, Tanase Y, Furukawa N, Yoshida S, Sado T, Kobayashi H. Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities. Cancer Invest 2012; 30: 473-480 [PMID: 22530740 DOI: 10.3109/07357907.2012.681821]
64. Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol 2009; 14: 383-391 [PMID: 19856044 DOI: 10.1007/s10147-009-0935-y]
65. van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ, Willemsen WN, Smeenk JM, Simons AH, van der Veen F, Evers JL, van Dop PA, Macklon NS, Burger CW. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod 2011; 26: 3456-3465 [PMID: 22031719 DOI: 10.1093/humrep/der322]